Zacks Small Cap Analysis – REVB Begins Trials with Good Money on Hand – Model Slux
By Brad Sorensen, CFA NASDAQ:REVB READ THE FULL REVBRESEARCH REPORT Revelation Biosciences (NASDAQ:REVB) is a life sciences firm targeted on the event of immunologic-based therapies for the prevention and therapy of illness. Revelation has a number of product candidates in growth that we consider have promising potential and are primarily based on the biology of … Read more